BeStock  
Stocks › Biotechnology › ACAD

ACADIA Pharmaceuticals ACAD

US equityMarket cap rank #2441Biotechnology
$17.11 −$0.48 (-2.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.12 +0.06%
Open$17.47
Prev close$17.59
Day range$17.05 – $17.79
Volume1.90M
Market cap$2.96B
P/E (TTM)8.1
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$31.77+85.7% vs. price
  • Buy 77%
  • Hold 23%
Low $23.00Now $17.11Avg $31.77High $38.00

Recent rating changes

The last 20 actions on file set price targets from $23.00 to $38.00, averaging $31.79.

DateFirmRatingTarget
13 Nov 2026 Morgan Stanley HOLD $24.00
10 Nov 2026 BofA Securities BUY $31.00
9 Nov 2026 BMO Capital BUY $34.00
6 Nov 2026 CCORF BUY $38.00
5 Nov 2026 TD Cowen BUY $37.00
5 Nov 2026 BofA Securities BUY –
5 Nov 2026 Morgan Stanley HOLD $28.00
5 Nov 2026 Oppenheimer HOLD $23.00
5 Nov 2026 RBC Capital BUY $38.00
4 Nov 2026 BMO Capital BUY $34.00
19 Oct 2026 Needham BUY $35.00
14 Oct 2026 UBS HOLD $23.00
13 Oct 2026 UBS HOLD $23.00
12 Oct 2026 BMO Capital BUY $34.00
9 Oct 2026 BofA Securities BUY $31.00
8 Oct 2026 RBC Capital BUY $36.00
5 Oct 2026 RBC Capital BUY $37.00
25 Sep 2026 Deutsche Bank BUY $31.00
25 Sep 2026 BMO Capital BUY $34.00
25 Sep 2026 H.C. Wainwright BUY $33.00

Discussion

No comments yet — be the first to weigh in on ACAD.

Sign in to join the discussion.

Scroll to Top